Ivabradine Shows Promise as Tx for Hyperadrenergic POTS

Further study needed in other POTS subtypes In patients with hyperadrenergic postural orthostatic tachycardia syndrome (POTS), one month of treatment with ivabradine brought about significant improvements in several parameters, including heart rate, quality of life (QOL), and plasma norepinephrine (NE) levels, according to results from a recent study published in the Journal of the American

Acute hyperhidrosis and postural tachycardia in a COVID-19 patient

Physiological effects of ivabradine in heart failure and beyond

Potential role of Ivabradine in children with Long Covid and a

Ivabradine Shows Promise as Tx for Hyperadrenergic POTS - Physician's Weekly

PDF) Ivabradine in Postural Orthostatic Tachycardia Syndrome: A

Acute hyperhidrosis and postural tachycardia in a COVID-19 patient

Ivabradine for the Treatment of Postural Orthostatic Tachycardia

PDF) Age-dependent modulation of xenobiotic metabolism in primary

Karsten HEUSSER, Senior Physician Scientist

Postural orthostatic tachycardia syndrome (POTS): a common but